Cahir MedTech

Cahir MedTech · Free video walkthrough

How CDRH Reviewers Actually Read Your Question Matrix

In about 4 minutes, explore how to frame focused Pre-Submission questions — so you can seek feedback that informs your test plan.

  • What makes a question specific, bounded and answerable
  • Weak vs. strong rewrites for testing, clinical and AI/ML questions
  • Red flags that lead to vague or non-committal feedback

Illustrative educational walkthrough, not an FDA meeting recording or FDA-endorsed training. On-screen captions with background music; no narration.

Keep the one-page summary — free

Five reviewer-ready checks, a question rewrite and next steps. Optional download with your work email — no registration needed to watch.

Your email is recorded for this download; no newsletter signup. Privacy policy

The 5-question reviewer checklist

  1. Is the question specific — one topic, one decision FDA can address?
  2. Does it state your proposed approach rather than asking what FDA wants?
  3. Is the rationale and supporting data summarized and clearly referenced?
  4. Is the scope bounded to this device, indication and test plan?
  5. Have you prioritized a manageable number of topics for focused feedback?

Frequently asked questions

What is a question matrix in an FDA Pre-Submission?

It is the organized list of specific questions a sponsor asks FDA in a Pre-Submission, each paired with the sponsor's proposed approach and supporting rationale. FDA's Q-Submission Program guidance asks sponsors to frame specific questions so the review team can give focused written feedback.

How many questions should a Pre-Submission include?

FDA's Q-Submission guidance recommends keeping the request to a manageable number of topics so the review team can address each one meaningfully. Grouping related issues and prioritizing the decisions that affect your test plan works better than a long list.

Why do open-ended questions get weak FDA feedback?

Asking what FDA wants gives the reviewer nothing to agree or disagree with. A question that proposes a specific method, sample size or endpoint, with a rationale, lets FDA confirm it or say what is missing — which is the feedback you can actually plan around.

Is the walkthrough video free?

Yes. Anyone can play the walkthrough without registering. An optional work-email form provides a free one-page companion summary PDF. The FDA Q-Sub Master Pack is a separate one-time purchase.

Source: FDA — Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program